Mr Sipp has occupied several high level posts in the German Federal Health Ministry, as well as working with the European Union. He was co-ordinator of the German delegation to the CND between 2001 and 2009. He has a positive record with respect to harm reduction.
At the African Union Specialized Technical Committee on Health, Population and Drug Control, IDPC reiterated the need for Africa to be very active in the global debate, and to have a common voice at the UNGASS and beyond.
Professor Mattick has conducted randomised control trials and published extensively on research into OST and the treatment of drug dependence. His is a psychologist by training.
Reasons for opposing the amendment to the Dangerous Drugs Act 1952 included usage of kratom as a traditional medication, lack of socio-economic considerations, and the need for evidence-based rehabilitation.
Dr Naidoo reiterates some of the main positions that the INCB has taken in recent years, in particular during his own presidency which has been characterised by greater attention on access to essential medicines.
On Friday 13th March, the Commision on Narcotic Drugs discussed the possible bringing of ketamine under international drug control, eventually deciding to differ the decision until more information was made available about the substance.
In this open letter, HCLU, ENPUD and the International HIV/AIDS Alliance in Ukraine ask the president of the INCB to act in order to protect the core principle of the international drug conventions: public health.
The overarching support for the availability of access to essential medicines that features in this year's Annual Report from the INCB is encouraging; but the INCB must direct its attention to what such support must mean on the ground, in those real places where pain is suffered.
The death penalty for drug offences represents the sharp end of the world’s failed war on drugs, disproportionately punishing the vulnerable while failing to tackle entrenched forces of crime and corruption.
The objectives of the workshop were to: build the capacity of key civil society partners from the region; strengthen their knowledge of drug policies and best practice; share experiences; showcase and discuss the ground-breaking report from the West Africa Commission; and further develop a West African Drug Policy Network.
